Protein kinase C activation by iridal type triterpenoids

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Biochemistry

Background:

• Iris tectorum and Belamcanda chinensis are traditional medicinal plants.
• Triterpenoids, such as iridals, are bioactive compounds found in these plants.
• Protein kinase C (PKC) is a key enzyme involved in cellular signaling pathways and disease development.

Purpose of the Study:

• To investigate the protein kinase C (PKC) activation and binding activities of iridal compounds from Iris tectorum and Belamcanda chinensis.
• To identify specific structural features of iridals responsible for PKC modulation.
• To evaluate the potential of these compounds as tumor promoters.

Main Methods:

• Isolation and purification of eleven iridal type triterpenoids from plant extracts.
• In vitro assays to measure protein kinase C (PKC) activation and binding affinity.
• Structure-activity relationship analysis to determine key structural requirements.

Main Results:

• Nine of the eleven tested iridals exhibited dose-dependent protein kinase C (PKC) activation and binding activities.
• A strong correlation was observed between PKC activation and binding.
• 28-Deacetylbelamcandal, a novel 12-O-tetradecanoylphorbol 13-acetate type tumor promoter, displayed the most potent activity.
• Essential structural features for activity include a hydrophobic side-chain, an E-methylidene aldehyde at C-1, and a hydroxyl group at C-26.

Conclusions:

• Iridals from Iris tectorum and Belamcanda chinensis possess significant protein kinase C (PKC) modulating properties.
• 28-Deacetylbelamcandal is a potent activator of PKC and a potential tumor promoter.
• Specific structural elements are critical for the biological activity of these iridals, providing insights for drug design.